Government has launched a new injectable contraceptive, Subcutaneous Medogen, aimed at expanding access to affordable and quality-assured family planning services for women. The product contains 104 milligrams of Medroxyprogesterone Acetate administered through a subcutaneous injection and provides protection against pregnancy for three months. Speaking during the launch, Minister of Health Professor Roma Chilengi, says the […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.